Novo Nordisk’s OpenAI Deal Isn’t About Drug Discovery — It’s About Owning the Next Cost Curve
Novo Nordisk's OpenAI partnership signals a new pharma AI arms race where pipeline economics, not just science, get rebuilt...
Pipeline Economics
Novo Nordisk's OpenAI partnership signals a new pharma AI arms race where pipeline economics, not just science, get rebuilt...